KALGENE PHAMACEUTICALS INC.

Profile

Company Names

KALGENE PHAMACEUTICALS INC.
KALGENE INC.

Addresses

6100 ROYALMOUNT AVENUE, NRC BUILDING, MONTREAL, A8 H4P2R2

Phone Numbers

(416) 697-9212

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

> 5 years ago

State Incorporated:

CANADA (FEDERAL LEVEL)

Total Amount Raised:

$4,762,843.00

Number of Funding Rounds:

1
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
1
2021-06-07 
$4,762,843.00 
$4,762,843.00 
$0.00 
Debt 
People
First Name
Middle Name
Last Name
Titles
Related Companies
JAMES 
ERIC 
CALLAWAY 
EXECUTIVE OFFICER, DIRECTOR
KALGENE PHAMACEUTICALS INC.
BENOIT 
 
CYR 
DIRECTOR
KALGENE PHAMACEUTICALS INC.   |  KALGENE INC.
ANTHONY 
J. 
GIOVINAZZO 
DIRECTOR
TITAN MEDICAL INC   |  KALGENE PHAMACEUTICALS INC.   |  KALGENE INC.   |  XORTX THERAPEUTICS INC.
DANIEL 
 
HETU 
DIRECTOR
THRASOS INNOVATION INC.   |  GLADIUS PHARMACEUTICALS CORP   |  KALGENE PHAMACEUTICALS INC.
JACKI 
 
JENUTH 
EXECUTIVE OFFICER, DIRECTOR
KALGENE PHAMACEUTICALS INC.
NICKOLAY 
V. 
KUKEKOV 
EXECUTIVE OFFICER
KALGENE PHAMACEUTICALS INC.   |  KALGENE INC.
MICHAL 
 
PRYWATA 
DIRECTOR
BIONIK LABORATORIES CORP.   |  PHANTOM SPACE CORP   |  KALGENE PHAMACEUTICALS INC.   |  KALGENE INC.
THILLAINATHAN 
 
YOGANATHAN 
DIRECTOR
KALGENE PHAMACEUTICALS INC.   |  KALGENE INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2022-01-20
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2021-06-07 
2021-09-28
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2021-06-07 
2021-06-22
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2021-06-07 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#